Skip to main content
. 2018 Apr 23;9:830. doi: 10.3389/fimmu.2018.00830

Figure 1.

Figure 1

Approaches for prophylactic (A) and therapeutic (B) vaccination for head and neck cancer. Abbreviations: VLP, virus-like particle; iTME, immunosuppressive tumour microenvironment; MDSC, myeloid-derived suppressor cell; Treg, regulatory T cell; CAF, cancer-associated fibroblast.